EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY

被引:290
作者
Imig, John D. [1 ]
机构
[1] Med Coll Wisconsin, Cardiovasc Res Ctr, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
ARACHIDONIC-ACID EPOXYGENASE; BOVINE CORONARY-ARTERIES; VASCULAR SMOOTH-MUSCLE; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; ACTIVATED-RECEPTOR-ALPHA; SALT-SENSITIVE HYPERTENSION; RED-BLOOD-CELLS; ASTROCYTIC EPOXYEICOSATRIENOIC ACID; RAT PREGLOMERULAR MICROVESSELS; INDUCED PULMONARY-HYPERTENSION;
D O I
10.1152/physrev.00021.2011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Imig JD. Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology. Physiol Rev 92: 101-130, 2012; doi: 10.1152/physrev.00021.2011.-Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that importantly contribute to vascular and cardiac physiology. The contribution of EETs to vascular and cardiac function is further influenced by soluble epoxide hydrolase (sEH) that degrades EETs to diols. Vascular actions of EETs include dilation and angiogenesis. EETs also decrease inflammation and platelet aggregation and in general act to maintain vascular homeostasis. Myocyte contraction and increased coronary blood flow are the two primary EET actions in the heart. EET cell signaling mechanisms are tissue and organ specific and provide significant evidence for the existence of EET receptors. Additionally, pharmacological and genetic manipulations of EETs and sEH have demonstrated a contribution for this metabolic pathway to cardiovascular diseases. Given the impact of EETs to cardiovascular physiology, there is emerging evidence that development of EET-based therapeutics will be beneficial for cardiovascular diseases.
引用
收藏
页码:101 / 130
页数:30
相关论文
共 333 条
[51]   CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products [J].
DeLozier, TC ;
Tsao, CC ;
Coulter, SJ ;
Foley, J ;
Bradbury, JA ;
Zeldin, DC ;
Goldstein, JA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03) :845-854
[52]   Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice [J].
Deng, Yangmei ;
Edin, Matthew L. ;
Theken, Katherine N. ;
Schuck, Robert N. ;
Flake, Gordon P. ;
Kannon, M. Alison ;
DeGraff, Laura M. ;
Lih, Fred B. ;
Foley, Julie ;
Bradbury, J. Alyce ;
Graves, Joan P. ;
Tomer, Kenneth B. ;
Falck, John R. ;
Zeldin, Darryl C. ;
Lee, Craig R. .
FASEB JOURNAL, 2011, 25 (02) :703-713
[53]   Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature [J].
Dhanasekaran, Anuradha ;
Al-Saghir, Rula ;
Lopez, Bernardo ;
Zhu, Daling ;
Gutterman, David D. ;
Jacobs, Elizabeth R. ;
Medhora, Meetha .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (02) :H517-H531
[54]   Protein phosphatase 2A and Ca2+-activated K+ channels contribute to 11,12-epoxyeicosatrienoic acid analog mediated mesenteric arterial relaxation [J].
Dimitropoulou, Christiana ;
West, Lashondra ;
Field, Mary B. ;
White, Richard E. ;
Manmohan Reddy, L. ;
Falck, John R. ;
Imig, John D. .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 83 (1-2) :50-61
[55]   An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats [J].
Dorrance, AM ;
Rupp, N ;
Pollock, DM ;
Newman, JW ;
Hammock, BD ;
Imig, JD .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (06) :842-848
[56]   The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension [J].
Dreisbach, AW ;
Japa, S ;
Sigel, A ;
Parenti, MB ;
Hess, AE ;
Srinouanprachanh, SL ;
Rettie, AE ;
Kim, H ;
Farin, FM ;
Hamm, LL ;
Lertora, JJL .
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (10) :1276-1281
[57]   TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels [J].
Earley, S ;
Heppner, TJ ;
Nelson, MT ;
Brayden, JE .
CIRCULATION RESEARCH, 2005, 97 (12) :1270-1279
[58]   Cytochrome P-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia [J].
Earley, S ;
Pastuszyn, A ;
Walker, BR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (01) :H127-H136
[59]   TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure [J].
Earley, Scott ;
Pauyo, Thierry ;
Drapp, Rebecca ;
Tavares, Matthew J. ;
Liedtke, Wolfgang ;
Brayden, Joseph E. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (03) :H1096-H1102
[60]   DILATION OF CEREBRAL ARTERIOLES BY CYTOCHROME-P-450 METABOLITES OF ARACHIDONIC-ACID [J].
ELLIS, EF ;
POLICE, RJ ;
YANCEY, L ;
MCKINNEY, JS ;
AMRUTHESH, SC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04) :H1171-H1177